Form 4: CompuGen Ltd. Executive Trades Ordinary Shares

CompuGen Ltd. SVP of Business Development, Zurit Levine, executed a Rule 10b5-1 plan transaction involving the acquisition and disposition of ordinary shares.

Summary

• Zurit Levine, SVP of Business Development at CompuGen Ltd., reported transactions on April 14, 2026.
• These transactions were conducted under a Rule 10b5-1 trading plan established on December 23, 2025.
• Levine acquired 2,000 ordinary shares at a price of $1.15 per share.
• Concurrently, Levine disposed of 2,000 ordinary shares at a price of $2.80 per share.
• Following these transactions, Levine beneficially owns 29,375 ordinary shares directly.
• Additionally, Levine holds a vested share option to purchase 2,000 ordinary shares at an exercise price of $1.15, with an expiration date of August 3, 2033.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While it involves insider transactions, the use of a Rule 10b5-1 plan mitigates negative sentiment, and the profitable spread within the plan suggests prudent financial management by the executive.

Positives

• The executive is actively managing their holdings through a pre-planned trading strategy (Rule 10b5-1), indicating a structured approach to personal investment.
• The acquisition of shares at a lower price ($1.15) and disposition at a higher price ($2.80) suggests a profitable execution within the trading plan.
• The executive continues to hold a significant number of shares (29,375) and a vested option, indicating continued confidence in the company.

Negatives

• The disposition of shares, even under a plan, could be perceived negatively by the market if not contextualized.
• The difference between the acquisition price ($1.15) and disposition price ($2.80) highlights a significant price fluctuation within the reporting period.

Risks

• Potential for negative market perception regarding insider selling, even if executed under a pre-arranged plan.
• The value of the remaining share option is subject to the future performance of CompuGen Ltd.'s stock price.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan by CompuGen Ltd.'s SVP of Business Development is a common strategy for executives to diversify holdings or manage personal finances while adhering to insider trading regulations. The specific prices indicate a profitable spread within the plan.

Stakeholder Impact

• Shareholders: The disposition of shares by an executive may be viewed with caution, though the Rule 10b5-1 plan provides a mitigating factor. The continued beneficial ownership indicates ongoing commitment.
• Employees: The executive's continued involvement and vested options signal confidence in the company's future, which can be a positive indicator for employee morale.
• Creditors: No direct impact is indicated by this filing.

Next Steps

• Continued adherence to the Rule 10b5-1 trading plan for any future transactions.
• Monitoring of CompuGen Ltd.'s stock performance in relation to the vested share option.

Key Dates

Keywords

Form 4, Insider Trading, CompuGen Ltd., CGEN, Ordinary Shares, Rule 10b5-1, Beneficial Ownership, Share Options, Zurit Levine